PepGen logo

PepGen

PEPG | NASDAQ
Chart Builder DCF Calculator
$4.19
-$0.17 (-3.90%)
At close: Nov 16, 2026, 4:00 PM ET
$4.16
-$0.03 (-0.70%)
After-hours: Nov 16, 2026, 7:58 PM ET
-3.90%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
34.5
+1.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #670/1021 (Top 66%)

Key Statistics

Market Data

Market Cap $290.2M
1D Range
4.10 4.34
52W Range
1.35 7.17

Valuation (TTM)

PE -3.41
PB 2.82
EV/EBITDA -2.82

Valuation (NTM)

Forward PE N/A
Forward PEG 0.07
Price Target $6.00
Loading financial charts...

Profile

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages i...

Sector Healthcare
Industry Biotechnology
Employees 57
IPO Date May 6, 2022
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$6.00
Upside
+43.20%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.